VEGFA and age-related macular degeneration: Nucleic acid aptamers [1]–[5] are an emerging class of therapeutic molecules, and a chemically-modified RNA aptamer Macugen® (Pegaptanib sodium), an inhibitor of vascular endothelial growth factor (VEGF) has been approved for the treatment of age related macular degeneration (AMD) [6], [7].